2019 EU Drug Markets Report from the EMCDDA and Europol

by European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) and European Union Agency for Law Enforcement Cooperation (Europol)
2019-EU-DRUG-MARKETS-REPORT-FROM-THE-EMCDDA-AND-EUROPOL

This report provides a strategic and action-oriented analysis of the information available on Europe’s drug market. It uses a broad definition of the illicit drug market, encompassing the illicit production, trafficking, wholesale distribution and sale of controlled substances to the end user. The drug market has wide-ranging impacts on both security and public health, and therefore such a holistic and systemic perspective is important for the effective delivery and monitoring of drug control policy.

Year
2019
  • WHO European region
  • Care and support
  • Co-infections
  • Harm reduction
  • Human rights
  • Inequalities in health
  • Laws and regulations
  • Legislation
  • Migration
  • Monitoring and Evaluation
  • Policy
  • Stigma and discrimination
  • Treatment
  • Health care professionals
  • NGOs
  • People living with HIV (PLHIV)
  • People who use drugs (PUD)
  • Policy makers

Tweeter news
@aidsactioneurop